col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


31 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Chinese Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―18 Temporal, spatial and demographic distributions characteristics of COVID-19 symptom clusters from chinese medicine perspective: a systematic cross-sectional study in China from 2019 to 2023 Bin Liu, Tian Song, Mingzhi Hu, Zhaoyuan Gong, Qianzi Che, Jing Guo, et al. (+9)
2 [GO] 2024―Jan―23 The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao Hui Mo, Man-Fei Zhou, Edmundo Patricio Lopes Lao, Ka-Kei Chan, On-Na Lai, Man-In Ho, et al. (+7)
3 [GO] 2023―Aug―02 Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro Min Zhang, Liting Liu, Yao Zhao, Yipeng Cao, Yan Zhu, Lifeng Han, et al. (+6)
4 [GO] 2022―Okt―28 Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis Xinxin Wang, Tao Ma, Wei Zhang, Qiang Chu
5 [GO] 2022―Okt―24 Correction: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study Linda Li-Dan Zhong, Yi-Ping Wong, Chor-Yin Leung, Bo Peng, Zhi-Xiu Lin, Vivian Chi-Woon Wong Taam, et al. (+15)
6 [GO] 2022―Aug―22 Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study Linda Li-Dan Zhong, Yi-Ping Wong, Chor-Yin Leung, Bo Peng, Zhi-Xiu Lin, Vivian Chi-Woon Wong Taam, et al. (+15)
7 [GO] 2022―Jul―27 An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, Shujun Xu, Ken Kin Lam Yung, Shaogang Qu, et al. (+2)
8 [GO] 2022―Jul―07 Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19 Liang Hong, Min He, Shaoping Li, Jing Zhao
9 [GO] 2022―Jun―21 The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis Lu Li, Hongliang Xie, Ling Wang, Aolin Zhang, Xuan Mou, Yifan Lin, et al. (+8)
10 [GO] 2022―Apr―02 Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial Xuedong An, Bo Peng, Xiaodong Huang, Hongmei Jiang, Zhang’e Xiong, Hong Zhang, et al. (+3)
11 [GO] 2022―Apr―01 Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro Qinhai Ma, Biao Lei, Ruihan Chen, Bin Liu, Wencong Lu, Haiming Jiang, et al. (+7)
12 [GO] 2022―Feb―28 Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review Xiaomin Kang, De Jin, Linlin Jiang, Yuqing Zhang, Yuehong Zhang, Xuedong An, et al. (+6)
13 [GO] 2021―Dez―03 Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies Mu-Feng Xiang, Cheng-Tao Jin, Li-Hua Sun, Zhi-Hui Zhang, Jing-Jing Yao, Liu-Cheng Li
14 [GO] 2021―Okt―18 The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2) Mingye Wang, Wenyan Li, Wenwen Cui, Yuanyuan Hao, Yao Mi, Hongtao Wang, et al. (+2)
15 [GO] 2021―Jul―28 Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review Yadong Fan, Ying Wang, Shuang Yu, Jun Chang, Yiqi Yan, Yiyang Wang, Yuhong Bian
16 [GO] 2021―Jul―27 Current status of traditional Chinese medicine for the treatment of COVID-19 in China Liang Chu, Fang Huang, Mengdan Zhang, Biao Huang, Yigang Wang
17 [GO] 2021―Jun―07 The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19 Xuedong An, Liyun Duan, Yue Hong Zhang, De Jin, Shenghui Zhao, Rong Rong Zhou, et al. (+3)
18 [GO] 2021―Mrz―03 The important herbal pair for the treatment of COVID-19 and its possible mechanisms Shujie Xia, Zhangfeng Zhong, Bizhen Gao, Chi Teng Vong, Xuejuan Lin, Jin Cai, et al. (+3)
19 [GO] 2021―Feb―22 Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19 Jillian L. Capodice, Barbara M. Chubak
20 [GO] 2020―Sep―25 Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review Jia-Wen Song, Jia-Ying Long, Long Xie, Lin-Lin Zhang, Qing-Xuan Xie, Hui-Juan Chen, et al. (+2)
21 [GO] 2020―Sep―03 Reflections on treatment of COVID-19 with traditional Chinese medicine Hua Luo, Yan Gao, Jian Zou, Siyuan Zhang, Hanbin Chen, Qiao Liu, et al. (+4)
22 [GO] 2020―Jul―30 Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking Lin Han, Xiu-Xiu Wei, Yu-Jiao Zheng, Li-Li Zhang, Xin-Miao Wang, Hao-Yu Yang, et al. (+3)
23 [GO] 2020―Jul―09 Current strategies against COVID-19 Shahid Hussain, Ya-Jia Xie, Dan Li, Shaukat Iqbal Malik, Jin-cai Hou, Elaine Lai-Han Leung, Xing-Xing Fan
24 [GO] 2020―Jun―12 Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking Xiaofeng Ruan, Peng Du, Kang Zhao, Jucun Huang, Hongmei Xia, Dan Dai, et al. (+4)
25 [GO] 2020―Jun―05 To Explore the Potential Mechanism of Yiqing Capsule in the Treatment of COVID-19 Based on Network Pharmacology Ying Wang, Jingyi Zhao, Yinhui Yao, Song Jiang, Xinhong Zhao, Junhui Hu
26 [GO] 2020―Jun―05 Body fluids may contribute to human-to-human transmission of severe acute respiratory syndrome coronavirus 2: evidence and practical experience Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Zhigang Xu, Xiangsheng Fu
27 [GO] 2020―Jun―04 Exploration on Shufeng Jiedu Capsule for Treatment of COVID-19 Based on Network Pharmacology and Molecular Docking Yanwu Zhao, Junhui Hu, Jiang Song, Xinhong Zhao, Yanjing Shi, Yanping Jiang
28 [GO] 2020―Mai―28 Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? Tuğçenur Uzun, Orcun Toptas
29 [GO] 2020―Mai―24 The potential insights of Traditional Chinese Medicine on treatment of COVID-19 Tong Tong, Ying-Qi Wu, Wei-Jian Ni, Ai-Zong Shen, Sheng Liu
30 [GO] 2020―Mai―14 Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection Yong Zeng, Bo Zhang, Xufeng Zhang, Cunjian Yi
31 [GO] 2020―Apr―15 Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China Erdan Luo, Daiyan Zhang, Hua Luo, Bowen Liu, Keming Zhao, Yonghua Zhao, et al. (+2)
 [1] 

31 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec